CurrentEndo
Get Weekly

Topic · page 10 of 12

Lipids & metabolic liver disease

Lipid disorders and metabolic dysfunction-associated steatotic (fatty) liver disease, as published in the endocrine journals

Briefs 361–400 of 460 placed here, newest publication first

Briefs in Lipids & metabolic liver disease

Newest publication first

  1. Obesity (Silver Spring)

    Noninvasive tests to identify liver fibrosis in metabolic dysfunction‐associated steatotic liver disease are affected by race

    Cross-sectional study

  2. Clin Endocrinol (Oxf)

    Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants

    Cross-sectional study

  3. Int J Obes (Lond)

    Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease

    Cross-sectional study

  4. J Clin Endocrinol Metab

    A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia

    Cohort study

  5. J Clin Endocrinol Metab

    Associations of Sedentary Time and Physical Activity From Childhood With Lipids: A 13-Year Mediation and Temporal Study

    Cohort study

  6. Cardiovasc Diabetol

    Triglyceride-glucose index is associated with a higher risk of stroke in a hypertensive population

    Cohort study

  7. Cardiovasc Diabetol

    Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study

    Cross-sectional study

  8. Cardiovasc Diabetol

    Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study

    Cohort study

  9. Cardiovasc Diabetol

    Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study

    Cohort study

  10. Pediatr Obes

    Endotoxin biomarkers, hepatic fat fraction, liver volume and liver stiffness among adolescents at high‐risk for non‐alcoholic fatty liver disease: The HEROES study

    Cross-sectional study

  11. Diabetes Res Clin Pract

    Physical activity intensity and markers of inflammation in those with non-alcoholic fatty liver disease

    Cross-sectional study

  12. Obesity (Silver Spring)

    Follistatin‐like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery

    Mechanistic study

  13. Cardiovasc Diabetol

    Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study

    Cohort study

  14. Cardiovasc Diabetol

    Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials

    Meta-analysis

  15. Cardiovasc Diabetol

    Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

    Cohort study

  16. Cardiovasc Diabetol

    Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study

    Cohort study

  17. Diabetes Obes Metab

    Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank

    Cohort study

  18. Cardiovasc Diabetol

    Association between the triglyceride–glucose index and left ventricular global longitudinal strain in patients with coronary heart disease in Jilin Province, China: a cross-sectional study

    Cross-sectional study

  19. Cardiovasc Diabetol

    Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population

    Cohort study

  20. Diabetes Obes Metab

    One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastography

    Cross-sectional study

  21. Cardiovasc Diabetol

    Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study

    Cross-sectional study

  22. J Clin Endocrinol Metab

    Serum Tsukushi Level Is Associated With the Severity of Liver Fibrosis Independent of Type 2 Diabetes

    Cross-sectional study

  23. Cardiovasc Diabetol

    The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease

    Cohort study

  24. Diabetes Obes Metab

    Repeated detection of non‐alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adults

    Cohort study

  25. J Clin Endocrinol Metab

    High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics

    Cross-sectional study

  26. Diabetologia

    Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy

    Secondary analysis

  27. Diabetes Res Clin Pract

    Unravelling the liver-brain connection: A two-sample Mendelian randomization study investigating the causal relationship between NAFLD and cortical structure

    Research article

  28. Obesity (Silver Spring)

    Genetic dissection of serum vaspin highlights its causal role in lipid metabolism

    Meta-analysis

  29. Cardiovasc Diabetol

    Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study

    Cohort study

  30. Obesity (Silver Spring)

    Metabolic syndrome‐related cognitive impairment with white matter hyperintensities and functional network analysis

    Cross-sectional study

  31. Diabetes Care

    Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

    Cohort study

  32. Endocr Pract

    Triglyceride Clearance in Hypertriglyceridemic Pancreatitis: Time Course and Its Implications for Management

    Cohort study

  33. Int J Obes (Lond)

    Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review

    Meta-analysis

  34. J Clin Endocrinol Metab

    The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty Liver Disease in Older Hypogonadal Men

    Secondary analysis

  35. Diabetes Metab

    Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke

    Cohort study

  36. J Clin Endocrinol Metab

    Acute Statin Withdrawal Does not Interfere With the Improvements of a Session of Exercise in Postprandial Metabolism

    Randomized controlled trial

  37. Clin Endocrinol (Oxf)

    Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study

    Research article

  38. Endocr Pract

    Associations of Sugar-Sweetened Beverages, Artificially Sweetened Beverages, and Pure Fruit Juice With Nonalcoholic Fatty Liver Disease: Cross-sectional and Longitudinal Study

    Cross-sectional study

  39. Diabetes Obes Metab

    Remnant cholesterol, but not low‐density lipoprotein cholesterol, is associated with intra‐pancreatic fat deposition

    Cross-sectional study

  40. JAMA Netw Open

    Community Social Capital and Population Health Outcomes

    Cross-sectional study

All 460 Briefs in ExploreShowing Briefs 361–400 of 460, newest first